<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000793028">
  <TermName>Zortress</TermName>
  <TermPronunciation>(ZOR-tres)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that contains the active ingredient everolimus and is used with other drugs to keep the body from rejecting a kidney or liver transplant. Zortress lowers the body’s immune response. It is a type of immunosuppressant and a type of kinase inhibitor.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000793631" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zortress&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000793630" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zortress&quot;" language="es" id="_4"/>
  <SpanishTermName>Zortress</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que contiene el principio activo everólimus y se usa con
otros medicamentos para evitar que el cuerpo rechace un trasplante de
riñón o de hígado. Zortress disminuye la respuesta inmunitaria del
cuerpo. Es un tipo de inmunodepresor y de
inhibidor de cinasas.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2018-04-16</DateFirstPublished>
  <DateLastModified>2021-05-18</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000640318" url="/about-cancer/treatment/drugs/everolimus">Everolimus</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
